Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 52 clinical trials
A Study Comparing MENOPUR in a Pen Formulation With a Powder and Solvent Formulation in Healthy Women

MENOPUR is a human menotrophin product, with a combination of human follicle-stimulating hormone (FSH) and luteinizing hormone (LH) activity. Human chorionic gonadotrophin (hCG) is the major

Accepts healthy volunteers
  • 0 views
  • 21 Mar, 2022
  • 1 location
Recombinant LH Prior to Ovarian Stimulation in Poor Ovarian Responders (PRE-LH)

described and oocyte donation is often offered as their only option to achieve pregnancy. Recently, evidence has emerged that supplementation with a specific hormone, luteinizing hormone (LH

body mass index
antral
luteinizing hormone
ovarian stimulation
antral follicle count
  • 0 views
  • 01 Sep, 2021
  • 3 locations
A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Prostate-Specific Membrane Antigen-Positron Emission Tomography (PSMA-PET) Positive Hormone-Sensitive Prostate Cancer Participants (PRIMORDIUM)

The main purpose of this study is to determine if the addition of apalutamide to radiotherapy (RT) plus luteinizing hormone-releasing hormone agonist (LHRHa) delays metastatic progression as

  • 5 views
  • 18 May, 2022
  • 75 locations
Prolonged Protocol of Early Follicular or Mid Luteal Phase

advantages in achieving ideal egg number, increasing endometrial receptivity to embryo transfer, inhibiting endogenous luteinizing hormone (LH) peak and reducing cycle cancellation rate. The full dose of

antral
gonadotropin
ovarian hyperstimulation
embryo transfer
antral follicle count
  • 41 views
  • 24 Jan, 2021
  • 1 location
Palbociclib for HR Positive / HER2-negative Isolated Locoregional Recurrence of Breast Cancer (POLAR)

modulator (such as tamoxifen) or an aromatase inhibitor (anastrozole, letrozole, exemestane) or fulvestrant (Faslodex). Premenopausal women and men may also receive a drug called an LHRH (luteinizing

hormone therapy
invasive breast cancer
HER2
gnrh
aromatase inhibitor
  • 2 views
  • 19 Feb, 2022
  • 55 locations
PALbociclib Rechallenge in horMone Receptor-posItive/HER2- Negative Advanced Breast Cancer (PALMIRA) (PALMIRA)

Hormone Receptor (HR)-positive/Human Epidermal Growth Factor Receptor 2 (HER2)-negative advanced breast cancer (ABC)

gonadotropin releasing hormone
hormone therapy
HER2
progesterone receptor
fulvestrant
  • 90 views
  • 30 Apr, 2022
  • 49 locations
Pozzi Forceps in Intrauterine Insemination

Many infertility and subfertility issues are treated nowadays with intrauterine inseminations. This is a minimally invasive technique that consists in placing sperm into a woman's uterus. Inseminations have only a fair success rate despite advances in technology ( 7 % per cycle). The goal of this study is to find …

secondary infertility
Accepts healthy volunteers
letrozole
unexplained infertility
ovulation induction
  • 106 views
  • 25 Feb, 2022
  • 1 location
GnRH Agonist for Dual Trigger in IVF and for Luteal Phase Support in FET

The objectives of this study are to compare the efficacy of the dual trigger group vs the hCG trigger group on the live birth rate in women undergoing IVF and the efficacy of the agonist in LP group vs the placebo group on the live birth rate in women undergoing …

gonadorelin
gonadotrophin releasing hormone analogue
  • 9 views
  • 02 Mar, 2022
  • 1 location
Luteinizing Hormone-releasing Hormone Analogue and Enzalutamide +/- Zoledronic Acid in Prostate Cancer Patients (BonEnza)

This study was undertaken to evaluate bone response in metastatic prostate cancer patients treated with Enzalutamide with or without Zoledronic Acid in combination with luteinizing hormone

bone scan
gonadotropin
enzalutamide
ct scan
cancer
  • 109 views
  • 02 Mar, 2022
  • 1 location
Does Spironolactone Normalize Sleep-wake Luteinizing Hormone Pulse Frequency in Pubertal Girls With Hyperandrogenism?

The purpose of this study is to determine if, in mid- to late pubertal girls with hyperandrogenism (HA), androgen-receptor blockade (spironolactone) alone normalizes sleep-wake luteinizing

  • 8 views
  • 28 Jan, 2021
  • 1 location